vitamin
va
pleiotrop
effect
immun
system
critic
mucos
immun
function
intestin
lymphocyt
traffick
hypothes
oral
va
supplement
porcin
epidem
diarrhea
viru
pedv
infect
pregnant
gilt
would
enhanc
gutmammari
glandsecretori
iga
axi
boost
lactogen
immun
passiv
protect
nurs
piglet
pedv
challeng
gilt
receiv
daili
oral
retinyl
acet
iu
start
gestat
day
throughout
lactat
week
prepartum
vasuppl
pedv
va
nonsuppl
pedv
gilt
pedv
mock
inocul
mock
va
mock
respect
pedv
va
gilt
decreas
mean
pedv
rna
shed
titer
diarrhea
score
determin
lactogen
immun
correl
protect
piglet
pedvchalleng
day
postpartum
surviv
rate
pedv
va
litter
compar
pedv
litter
mock
mock
va
litter
surviv
rate
respect
pedv
va
gilt
increas
pedv
iga
antibodi
secret
cell
pedv
iga
antibodi
serum
prepartum
iga
gut
home
cell
milk
post
piglet
challeng
compar
pedv
gilt
find
suggest
oral
va
supplement
may
act
adjuv
pregnanc
enhanc
matern
iga
lactogen
immun
protect
nurs
piglet
diarrheal
diseas
repres
major
global
health
burden
lead
caus
morbid
mortal
young
human
anim
alik
young
anim
diarrheal
diseas
account
estim
multimillion
dollar
loss
annual
livestock
industri
due
mortal
reduc
weight
gain
treatment
cost
trade
sanction
export
anim
product
infect
countri
passiv
lactogen
immun
provid
protect
igg
colostrum
continu
suppli
secretori
iga
siga
milk
play
signific
role
confer
protect
enter
pathogen
neonat
exampl
higher
pathogenspecif
iga
antibodi
ab
titer
milk
associ
lower
incid
enter
diseas
pig
children
addit
boost
matern
immun
respons
may
benefici
consequ
mother
provid
protect
diseas
pregnanc
lactat
enhanc
immun
matern
vaccin
potenti
provid
dual
benefit
immun
protect
motherneonat
dyad
porcin
epidem
diarrhea
viru
pedv
alphacoronaviru
caus
acut
diarrhea
dehydr
mortal
neonat
piglet
adult
pig
pedv
caus
wateri
diarrhea
depress
anorexia
well
agalactia
reduc
reproduct
perform
due
high
virul
pedv
immatur
immun
system
neonat
piglet
passiv
lactogen
immun
pedv
induc
via
gutmammari
gland
mg
siga
axi
pregnanc
lactat
remain
promis
effect
way
protect
nurs
piglet
pedvinduc
diseas
provid
suffici
pedvspecif
lactogen
immun
depend
traffick
iga
antibodi
secret
cell
asc
intestin
mg
accumul
siga
ab
milk
howev
littl
known
regard
antivir
humor
immun
respons
pregnanc
level
lactogen
immun
protect
gener
induct
gutmgsiga
axi
variabl
inde
lab
demonstr
third
trimest
pedvinfect
gilt
provid
insuffici
passiv
lactogen
immun
protect
pedvchalleng
nurs
piglet
compar
second
first
trimest
pedvinfect
gilt
therefor
identifi
cost
effect
strategi
stimul
enhanc
traffick
pedv
iga
asc
mg
accumul
pedv
siga
ab
milk
pregnant
swine
model
critic
develop
matern
vaccin
therapeut
improv
matern
lactogen
immun
neonat
health
retino
acid
ra
vitamin
va
metabolit
pleiotrop
effect
immun
system
exampl
va
defici
vad
individu
serum
retinol
level
suscept
enter
respiratori
diseas
young
children
highest
risk
specif
va
requir
enhanc
regul
immun
respons
cellular
traffick
gut
lamina
propria
lp
dendrit
cell
dc
synthes
ra
express
retin
dehydrogenas
ie
synergist
local
produc
cytokin
lp
dc
upregul
mucos
traffick
adhes
molecul
integrin
chemokin
cc
receptor
ccr
express
b
lymphocyt
interact
peyer
patch
mesenter
lymph
node
mln
exampl
vad
mice
significantli
decreas
memori
cell
lymphoid
organ
cell
lp
addit
vad
alter
cytokin
respons
infect
skew
toward
increas
thelper
cell
cytokin
respons
infant
mice
treatment
cell
nm
ra
vitro
result
shift
toward
cytokin
respons
promot
immunoregulatori
environ
therefor
even
subclin
defici
va
may
neg
impact
mucos
lymphocyt
traffick
gut
homeostasi
pregnanc
also
relev
mucos
immun
respons
role
ra
b
cell
differenti
iga
product
use
gnotobiot
pig
model
lab
demonstr
subclin
vad
piglet
decreas
frequenc
lp
dc
result
decreas
adapt
immun
respons
human
rotaviru
hrv
prolong
diarrhea
vad
gnotobiot
piglet
vaccin
attenu
hrv
demonstr
higher
diarrhea
sever
post
hrv
challeng
compar
vaccin
va
suffici
piglet
coincid
lower
serum
iga
hrv
ab
titer
significantli
decreas
intestin
iga
asc
postchalleng
suggest
compromis
anamnest
immun
respons
howev
paramet
impact
va
supplement
pregnanc
gutmgsiga
axi
passiv
neonat
immun
larg
undefin
therefor
hypothes
oral
va
supplement
pedvinfect
pregnant
gilt
would
enhanc
traffick
iga
asc
gut
mg
lead
increas
accumul
siga
ab
milk
passiv
lactogen
protect
pedvchalleng
nurs
piglet
risk
subclin
clinic
vad
increas
gestat
age
due
acceler
growth
fetu
physiolog
increas
blood
volum
swine
human
dietari
va
recommend
given
swine
repres
physiologicallybas
mathemat
model
develop
rel
diseasefre
environ
therefor
like
dietari
va
requir
pregnanc
effici
stimul
gutmgsiga
axi
provid
suffici
lactogen
immun
protect
neonat
enter
viral
infect
higher
current
dietari
recommend
investig
impact
daili
oral
va
supplement
gestat
lactat
supplement
gilt
nonteratogen
yet
physiolog
relev
level
oral
retinyl
acet
intern
unit
iu
daili
start
begin
third
trimest
last
throughout
lactat
demonstr
daili
oral
va
supplement
pedvinfect
gilt
decreas
diarrhea
increas
number
pedv
iga
asc
pedv
iga
ab
serum
prepartum
iga
immunoglobulin
secret
cell
igsc
iga
cell
milk
post
piglet
challeng
provid
greater
lactogen
immun
protect
neonat
nurs
piglet
wildtyp
strain
pedv
use
gilt
infect
piglet
challeng
dose
plaqu
form
unit
dilut
minim
essenti
media
mem
life
technolog
carlsbad
ca
usa
briefli
isol
cultur
vero
cell
describ
previous
cell
grown
growth
medium
contain
dulbecco
modifi
eagl
medium
dmem
life
technolog
carlsbad
ca
usa
supplement
fetal
bovin
serum
life
technolog
carlsbad
ca
usa
antibioticantimycot
life
technolog
carlsbad
ca
usa
viru
grown
vero
cell
mainten
medium
contain
dmem
supplement
trypsin
life
technolog
carlsbad
ca
tryptos
phosphat
broth
sigma
aldrich
st
loui
mo
usa
antibioticantimycot
cell
kept
humidifi
incub
co
passag
three
time
vero
cell
passag
gener
inoculum
gnotobiot
pig
virul
pig
passag
confirm
adult
neonat
pig
describ
previous
cellcultur
adapt
use
posit
control
viru
neutral
vn
ab
assay
anim
experi
approv
institut
anim
care
use
committe
ohio
state
univers
method
carri
accord
approv
protocol
relev
regul
pig
maintain
sampl
euthan
human
first
pariti
pedv
transmiss
gastroenter
viru
tgev
seroneg
pregnant
gilt
landrac
yorkshir
duroc
crossbr
arriv
facil
either
ohio
state
univers
swine
center
facil
commerci
swine
herd
gestat
day
gd
hous
individu
open
pen
gestat
major
lactat
gilt
place
farrow
crate
day
prior
expect
farrow
day
postpartum
ensur
safe
deliveri
interact
piglet
artifici
light
regul
lightdark
timer
howev
natur
light
also
enter
anim
room
nearbi
window
gilt
randomli
assign
one
four
treatment
group
meminfect
mock
n
meminfect
daili
oral
va
supplement
mock
va
n
third
trimest
gd
day
prepartum
pedvinfect
pedv
n
third
trimest
pedvinfect
daili
oral
va
supplement
pedv
va
n
vasuppl
gilt
oral
receiv
iuday
retinyl
acet
gd
throughout
lactat
figur
consid
circadian
natur
traffick
lymphocyt
retinyl
acet
supplement
two
time
per
day
iu
h
iu
h
gilt
fecal
sampl
collect
clinic
sign
observ
postpedv
infect
day
pid
fecal
consist
score
follow
solid
pasti
semiliquid
liquid
respect
fecal
consist
score
consid
diarrhea
blood
sampl
taken
pid
serum
mononuclear
cell
mnc
isol
figur
gilt
natur
farrow
facil
gd
colostrum
collect
within
h
parturit
piglet
allow
suckl
natur
birth
kept
mother
throughout
lactat
piglet
oral
pedvchalleng
day
age
figur
gilt
piglet
serum
collect
post
piglet
challeng
day
pcd
colostrum
milk
sampl
collect
administr
cc
oxytocin
intramuscularli
im
postpartum
day
ppd
figur
gilt
mg
biopsi
collect
gd
ppd
piglet
fecal
sampl
collect
clinic
sign
bodi
weight
record
daili
pcd
everi
day
pcd
anim
euthan
pcd
gilt
blood
ileum
mg
mln
spleen
tissu
collect
mnc
isol
piglet
blood
collect
serum
separ
immunolog
assay
serum
sampl
collect
report
previous
submit
diagnost
center
popul
anim
health
michigan
state
univers
lans
mi
usa
quantit
va
concentr
hplc
determin
pedv
rna
shed
titer
two
rectal
swab
suspend
ml
mem
describ
previous
viral
rna
extract
fecal
supernat
follow
centrifug
g
min
use
magmax
viral
rna
isol
kit
appli
biosystem
foster
citi
ca
usa
accord
manufactur
instruct
titer
viral
rna
shed
fece
determin
taqman
rtqpcr
use
onestep
rtpcr
kit
qiagen
valencia
ca
usa
describ
previous
detect
limit
copi
per
reaction
correspond
log
copiesml
origin
fecal
sampl
blood
spleen
mg
mln
ileum
collect
asept
euthanasia
process
mnc
isol
describ
previous
isol
cell
resuspend
enrich
rpmi
erpmi
roswel
park
memori
institut
medium
contain
fetal
bovin
serum
mm
lglutamin
mm
sodium
pyruv
mm
nonessenti
amino
acid
mm
hepe
acid
antibioticantimycot
life
technolog
carlsbad
ca
usa
use
assay
viabil
mnc
determin
trypan
blue
exclus
briefli
mnc
dilut
twofold
trypan
blue
visual
use
autom
cell
counter
cellomet
nexcelom
lawrenc
usa
viabil
calcul
number
blue
cellsnumb
total
cell
serum
sampl
pedv
pedv
va
gilt
process
analyz
proinflammatori
tumor
necrosi
factor
tnf
interleukin
il
innat
interferon
ifn
regulatoryantiinflammatori
transform
growth
factor
tgf
cytokin
describ
previous
colostrummilk
collect
asept
gilt
given
cc
oxytocin
veton
bois
id
usa
im
facilit
collect
mammari
secret
sampl
filter
pore
filter
centrifug
g
min
separ
fat
skim
milk
cell
pellet
portion
fat
remov
util
steril
plaintip
applic
fisher
scientif
hampton
nh
usa
skim
milk
collect
centrifug
g
h
separ
whey
store
test
colostrum
milk
mnc
isol
describ
previous
viabil
mnc
determin
trypan
blue
exclus
plaqu
reduct
vn
assay
perform
describ
previous
plaqu
count
vn
titer
determin
take
reciproc
highest
dilut
serumwhey
sampl
show
reduct
number
plaqu
compar
seroneg
control
serumwhey
sampl
neg
dilut
assign
titer
calcul
geometr
mean
titer
gmt
pedv
whole
viru
ab
elisa
perform
describ
previous
elisa
ab
titer
express
reciproc
highest
dilut
correct
valu
sampl
absorb
virusco
well
minu
sampl
absorb
mock
antigenco
well
greater
cutoff
valu
mean
correct
valu
neg
control
plu
standard
deviat
sampl
neg
dilut
assign
titer
calcul
gmt
enumer
total
igsc
pedvspecif
asc
perform
describ
previous
count
averag
duplic
well
express
rel
mnc
pedv
ab
cell
mg
analyz
describ
previous
microscop
imag
magnif
obtain
use
fluoresc
microscop
olympu
mean
number
pedv
ab
cell
evalu
measur
least
differ
tissu
area
magnif
sampl
time
point
gd
pcd
mock
mock
va
pedv
pedv
va
gilt
procedur
flow
cytometri
stain
includ
buffer
use
perform
describ
previous
minor
modif
briefli
mnc
cellsml
stain
antiporcin
clone
southern
biotech
antiporcin
clone
vmrd
monoclon
ab
determin
b
cell
subset
determin
express
integrin
integrin
cell
stain
porcin
crossreact
antihuman
integrin
clone
abcam
cambridg
antimous
integrin
clone
bd
bioscienc
monoclon
ab
addit
determin
express
iga
cell
stain
antiporcin
iga
clone
biorad
monoclon
ab
wash
cell
stain
appropri
secondari
antibodi
intracellular
stain
cell
permeabil
cytofixcytoperm
bd
bioscienc
wash
perm
wash
buffer
bd
bioscienc
stain
porcin
crossreact
antimous
ab
clone
biorad
monoclon
ab
addit
antiporcin
clone
southern
biotech
antiporcin
clone
southern
biotech
cell
assess
within
antiporcin
clone
southern
biotech
mnc
popul
lymphocyt
appropri
isotyp
match
control
ab
includ
acquisit
event
analys
done
use
accuri
flow
cytomet
bd
bioscienc
san
jose
ca
usa
cell
first
gate
singlet
fsch
vs
fsca
mnc
ssca
vs
fsca
determin
b
cell
subset
mnc
popul
analyz
express
iga
mnc
determin
within
popul
describ
previous
twoway
analysi
varianc
anovagener
linear
model
follow
bonferroni
posttest
use
compar
serum
va
concentr
pedv
rna
shed
titer
fecal
consist
score
mean
concentr
serum
cytokin
frequenc
blood
mnc
popul
flow
cytometri
pedv
iga
igg
asc
logtransform
pedv
iga
igg
vn
ab
titer
normal
weight
pedv
ab
cell
mg
frequenc
cell
popul
pedv
iga
igg
asc
milk
ileum
compar
among
group
mannwhitney
nonparametr
test
logrank
mantelcox
test
use
comparison
surviv
curv
amongst
treatment
group
statist
signific
assess
p
comparison
assay
run
investig
blind
sampl
treatment
identif
prior
analysi
statist
analys
random
number
gener
treatment
random
perform
graphpad
prism
graphpad
softwar
inc
ca
usa
oral
va
supplement
third
trimest
gilt
significantli
alter
mean
serum
va
concentr
howev
gilt
va
pool
trend
decreas
mean
serum
va
concentr
immedi
prior
parturit
figur
mean
pedv
rna
shed
titer
consist
numer
lower
pid
rapid
rate
decreas
mean
pedv
rna
shed
titer
pid
pedv
va
compar
pedv
gilt
figur
addit
mean
fecal
consist
score
pid
significantli
lower
pedv
va
compar
pedv
gilt
figur
trend
higher
type
ii
interferon
respect
pid
pedv
pedv
va
gilt
immunoregulatori
cytokin
increas
numer
pid
pedv
va
compar
pedv
gilt
addit
file
addit
trend
increas
mean
concentr
cytokin
promot
tissu
regener
repair
gut
pid
pedv
va
compar
pedv
gilt
addit
file
trend
observ
serum
concentr
addit
file
oral
va
significantli
increas
prepartum
level
circul
pedv
iga
asc
ab
iga
mnc
mean
number
circul
pedv
iga
asc
significantli
higher
pid
pedv
va
compar
pedv
gilt
figur
b
pedv
va
gilt
significantli
higher
mean
frequenc
circul
b
cell
normal
pid
compar
mock
gilt
pid
figur
pedv
va
gilt
also
significantli
higher
mean
frequenc
circul
iga
mnc
normal
pid
pid
compar
mock
pedv
gilt
figur
wherea
signific
differ
seen
prepartum
level
circul
pedv
igg
asc
igg
ab
vn
ab
post
pedv
infect
addit
file
pedv
iga
ab
titer
significantli
higher
pid
pedv
va
compar
pedv
gilt
figur
piglet
pedvchalleng
day
age
determin
impact
matern
va
supplement
lactogen
immun
piglet
morbid
figur
daili
oral
va
supplement
significantli
decreas
diarrhea
pedv
infect
gilt
viru
shed
determin
realtim
quantit
polymeras
chain
reaction
rtqpcr
express
log
copiesml
b
diarrhea
determin
fecal
consist
score
fecal
consist
score
follow
normal
pastysemiliquid
liquid
wateri
differ
alphabet
letter
indic
signific
differ
among
treatment
group
mean
sem
statist
analysi
perform
use
twoway
anova
repeat
measur
bonferroni
correct
multipl
comparison
p
mortal
surviv
rate
pedv
va
litter
compar
pedv
litter
mock
mock
va
piglet
surviv
rate
respect
figur
comparison
piglet
weight
gain
reveal
pedv
va
litter
significantli
higher
normal
weight
pcd
compar
pedv
litter
figur
addit
mock
litter
va
stunt
decreas
weight
gain
pcd
lowest
normal
weight
throughout
studi
although
normal
mean
weight
pid
higher
mock
va
compar
mock
piglet
data
repres
two
surviv
piglet
respect
treatment
group
pedv
va
piglet
significantli
decreas
pedv
rna
shed
titer
pcd
lower
delay
mean
peak
shed
titer
compar
pedv
piglet
figur
significantli
differ
piglet
pedv
va
pedv
gilt
fecal
consist
score
decreas
faster
rate
pcd
pedv
va
compar
pedv
litter
figur
va
supplement
mock
gilt
result
decreas
morbid
mortal
pedvchalleng
piglet
determin
impact
matern
va
supplement
lactogen
immun
adapt
immun
paramet
measur
colostrum
milk
mean
pedv
iga
asc
milk
significantli
higher
ppd
pcd
pedv
va
compar
pedv
gilt
figur
addit
mean
milk
iga
figur
circul
pedv
specif
iga
asc
significantli
increas
pedv
va
gilt
prepartum
b
peripher
blood
mnc
pbmc
isol
ad
pedv
elispot
plate
determin
pedv
specif
iga
asc
c
pbmc
isol
analyz
frequenc
b
cell
iga
mnc
flow
cytometri
e
pedv
iga
ab
determin
elisa
asterisk
indic
signific
differ
among
treatment
group
time
point
mean
sem
frequenc
b
cell
iga
mnc
normal
divid
postchalleng
day
pcd
frequenc
statist
analysi
perform
use
twoway
anova
repeat
measur
bonferroni
correct
multipl
comparison
p
p
p
igsc
ppd
pcd
significantli
higher
pedv
va
compar
pedv
gilt
time
point
figur
c
milk
mnc
pedv
va
gilt
isol
stain
express
iga
mucos
home
receptor
integrin
mean
milk
iga
cell
frequenc
numer
higher
p
pedv
va
compar
pedv
gilt
ppd
pcd
figur
due
high
mortal
rate
mock
va
litter
mg
mock
gilt
regress
rapidli
therefor
enough
milk
avail
mock
gilt
isol
mnc
ppd
pcd
mean
pedv
iga
vn
ab
titer
numer
higher
ppd
pcd
iga
ab
ppd
pcd
ppd
pcd
pedv
vn
ab
pedv
va
compar
pedv
gilt
significantli
higher
pedv
va
compar
mock
va
gilt
similar
time
point
figur
f
consist
hypothesi
iga
asc
milk
may
play
role
lactogen
immun
protect
neonat
piglet
pedv
challeng
weight
normal
divid
daili
weight
lb
pcd
weight
lb
c
diarrhea
determin
fecal
consist
score
fecal
consist
score
follow
normal
pastysemiliquid
liquid
wateri
viru
shed
determin
real
time
quantit
polymeras
chain
reaction
rtqpcr
express
log
copiesml
piglet
diarrhea
score
viral
shed
measur
pcd
differ
alphabet
letter
indic
signific
differ
among
treatment
group
time
point
mean
sem
statist
analysi
perform
use
logrank
mantelcox
test
twoway
anova
repeat
measur
bonferroni
correct
multipl
comparison
bd
differ
mean
pedv
ab
cell
per
microscop
field
gilt
gd
pedv
va
compar
pedv
gilt
figur
b
pedv
ab
cell
mg
mock
mock
va
gilt
gd
pedv
va
pedv
gilt
significantli
higher
number
pedv
ab
cell
per
microscop
field
mg
pcd
compar
mock
gilt
va
figur
b
circul
level
pedv
iga
asc
pedv
iga
ab
pedv
vn
ab
measur
pcd
gilt
piglet
circul
mean
number
pedv
iga
asc
pedv
va
gilt
significantli
higher
pcd
compar
mock
va
gilt
figur
howev
mock
va
gilt
significantli
higher
circul
pedv
iga
asc
compar
pedv
gilt
ppd
figur
mean
pedv
iga
ab
titer
numer
higher
pcd
pedv
va
compar
pedv
gilt
figur
pedv
gilt
va
significantli
elev
level
pedv
iga
asc
ab
vn
ab
pcd
compar
mock
gilt
va
demonstr
anamnest
respons
pedv
gilt
va
figur
piglet
mean
pedv
iga
ab
titer
higher
pedv
va
compar
pedv
numer
mock
significantli
litter
pcd
figur
addit
piglet
serum
mean
pedv
iga
ab
titer
increas
treatment
group
post
piglet
challeng
figur
gilt
mg
spleen
mln
ileum
tissu
analyz
pedv
iga
igg
asc
pcd
mean
number
iga
asc
spleen
mln
numer
higher
pcd
mock
va
compar
pedv
va
gilt
figur
va
supplement
gilt
mock
pedv
group
significantli
higher
number
mean
pedv
iga
asc
ileum
compar
respect
nonsuppl
treatment
group
figur
pedv
igg
asc
spleen
significantli
higher
mock
va
compar
pedv
va
gilt
figur
addit
mock
gilt
significantli
higher
pedv
igg
asc
ileum
compar
pedv
gilt
figur
due
high
mortal
rate
mock
va
litter
mg
mock
gilt
regress
rapidli
therefor
enough
mg
tissu
avail
isol
mnc
measur
pedv
iga
igg
asc
addit
mean
frequenc
ileal
b
cell
numer
higher
pedv
va
compar
pedv
gilt
figur
knowledg
first
studi
evalu
effect
va
supplement
matern
lactogen
immun
enter
viral
infect
swine
vitamin
critic
mediat
mucos
immun
function
essenti
lymphocyt
traffick
gut
exampl
vad
lead
increas
suscept
bacteri
viral
pathogen
va
supplement
allevi
neg
effect
certain
infecti
diseas
particularli
relev
pregnanc
neonat
period
greater
risk
clinic
subclin
vad
investig
impact
va
matern
lactogen
immun
supplement
third
trimest
pedvinfect
gilt
oral
retinyl
acet
begin
gd
throughout
lactat
demonstr
va
supplement
pedvinfect
gilt
decreas
fecal
consist
score
third
trimest
gilt
also
pedv
iga
asc
ab
iga
igsc
iga
b
cell
blood
andor
milk
greater
pedv
va
gilt
coincid
greater
mean
surviv
rate
pedvchalleng
nurs
piglet
find
suggest
daili
oral
va
supplement
pregnanc
may
act
mucos
adjuv
enhanc
matern
iga
lactogen
immun
pedv
infect
current
va
recommend
swine
iukg
feed
iuday
gestat
iukg
feed
fed
ad
libitum
lactat
howev
recommend
develop
assum
diseasefre
environ
consid
serum
va
concentr
swine
decreas
increas
gestat
pariti
vlasova
lj
saif
unpublish
observ
like
dietari
va
recommend
gestat
gilt
sow
suboptim
viral
bacteri
infect
due
limit
avail
studi
vitamin
supplement
pregnant
swine
reli
literatur
speci
inform
dose
decis
femal
childbear
age
vitamin
apoor
diet
given
singl
oral
dose
iu
retinyl
palmit
produc
doserel
sustain
increas
plasma
retinyl
ester
retino
acid
addit
supplement
pregnant
women
oral
dose
iuday
vitamin
result
enhanc
figur
serum
iga
antibodi
ab
pedv
va
gilt
increas
higher
level
faster
rate
mock
va
gilt
serum
pedv
iga
antibodi
secret
cell
asc
b
ab
respons
determin
pedv
elispot
elisa
assay
respect
c
serum
pedv
viru
neutral
vn
ab
respons
determin
vn
assay
piglet
serum
circul
pedv
iga
titer
measur
elisa
gilt
piglet
serum
collect
piglet
postchalleng
day
pcd
asterisk
indic
signific
differ
among
treatment
group
time
point
mean
sem
statist
analysi
perform
use
twoway
anova
repeat
measur
bonferroni
correct
multipl
comparison
p
p
p
prenat
respons
mother
therefor
viral
infect
swine
pregnanc
result
subclin
vitamin
defici
reason
iu
would
appropri
dose
elicit
physiolog
immunolog
respons
addit
base
nonhuman
primat
data
oral
dose
iu
retino
acid
nonteratogen
inde
presum
upper
safe
level
dietari
va
ten
time
nutrit
requir
swine
previou
studi
harm
effect
va
toxic
observ
swine
time
nutrit
requir
given
extend
period
time
therefor
reason
daili
oral
va
supplement
iu
start
third
trimest
last
throughout
lactat
unlik
caus
harm
effect
inde
sign
hypervitaminosi
observ
gilt
piglet
serum
retinol
concentr
homeostat
control
rang
adequ
liver
store
therefor
surpris
studi
oral
va
supplement
chang
serum
retinol
concentr
gilt
addit
rate
intestin
va
metabol
oral
supplement
contribut
system
exposur
va
metabolit
exampl
feedrestrict
lactat
sow
fed
acet
vitamin
serum
ester
concentr
peak
h
postprandi
return
near
baselin
level
h
transient
increas
serum
va
concentr
unlik
would
detect
blood
collect
gilt
immedi
prior
va
supplement
h
similar
previou
find
swine
human
studi
demonstr
decreas
mean
serum
retinol
concentr
immedi
prior
parturit
coincid
time
chemokin
secret
express
cognat
receptor
increas
mg
recruit
circul
asc
colostrum
milk
result
highlight
import
understand
role
va
pregnanc
potenti
effect
matern
immun
gutmgsiga
enter
viral
infect
observ
lower
faster
declin
mean
peak
pedv
rna
shed
titer
significantli
decreas
fecal
consist
score
pid
pedv
va
compar
pedv
gilt
suggest
oral
va
supplement
may
enhanc
innat
immun
protect
pedv
third
trimest
gilt
exampl
previou
studi
rat
mice
report
decreas
nk
cell
frequenc
function
vad
supplement
va
precursor
vivo
vitro
increas
nk
cell
cytotox
activ
agreement
previou
work
lab
demonstr
associ
increas
nk
cell
frequenc
blood
decreas
clinic
sign
pedvchalleng
piglet
pedv
infect
associ
local
system
inflamm
increas
concentr
serum
innat
proinflammatori
cytokin
inde
protect
pedvinduc
diseas
associ
delay
serum
proinflammatori
cytokin
post
pedv
challeng
piglet
find
demonstr
trend
wherebi
pedv
va
gilt
numer
reduc
mean
proinflammatori
cytokin
increas
immunoregulatori
tissu
repair
cytokin
respect
coincid
significantli
decreas
diarrhea
score
compar
pedv
gilt
respons
may
aid
establish
gut
homeostasi
therebi
reduc
sever
pedv
infect
third
trimest
gilt
oral
va
supplement
significantli
increas
prepartum
level
circul
pedv
iga
asc
iga
mnc
pedv
iga
ab
post
pedv
infect
exampl
signific
increas
circul
pedv
iga
ab
asc
pid
respect
coincid
significantli
increas
normal
iga
cell
pedv
va
gilt
suggest
oral
va
supplement
increas
migrat
pedv
stimul
b
cell
intestin
circul
post
pedv
infect
inde
traffick
iga
asc
predomin
lymphoid
tissu
gut
migrat
circul
intestin
infect
agreement
previou
studi
lab
demonstr
iga
asc
domin
respons
intestin
tgev
pedv
rv
infect
swine
lab
also
previous
demonstr
va
statu
influenc
antivir
b
cell
immun
exampl
hrvvaccin
va
suffici
piglet
increas
hrv
specif
iga
asc
ab
duodenum
post
hrv
challeng
compar
vaccin
vad
piglet
furthermor
mucos
associ
adhes
receptor
imprint
immun
cell
respond
tissuespecif
immun
interact
exampl
integrin
express
intestin
lymphocyt
increas
interact
va
synthes
dc
intestin
peyer
patch
promot
cellular
migrat
gut
mucosa
lymphoid
tissu
studi
mean
frequenc
b
cell
normal
pid
increas
numer
pedv
va
gilt
pid
mean
frequenc
iga
b
cell
significantli
higher
pid
pedv
va
compar
mock
pedv
gilt
suggest
va
supplement
may
influenc
migrat
iga
cell
pedv
infect
studi
pedvchalleng
litter
pedv
va
gilt
higher
surviv
rate
significantli
decreas
pedv
rna
shed
titer
pcd
trend
lower
mean
fecal
consist
score
pcd
increas
surviv
rate
pedv
va
litter
coincid
higher
frequenc
circul
b
cell
pid
normal
pid
gilt
iga
igsc
milk
ppd
pcd
result
agreement
previou
work
lab
demonstr
increas
lactogen
immun
protect
pedv
nurs
piglet
correl
pedv
iga
asc
ab
milk
addit
tgevinfect
sow
high
rate
protect
associ
high
titer
iga
ab
colostrum
milk
similar
find
also
report
mice
supplement
prova
metabolit
pregnanc
lactat
increas
iga
igsc
mg
lactat
signific
differ
milk
pedv
iga
asc
total
iga
igsc
pedv
va
gilt
limit
post
piglet
pedv
challeng
time
point
suggest
role
va
enhanc
anamnest
lactogen
immun
respons
futur
studi
investig
role
va
milk
mg
memori
b
cell
function
swine
warrant
differ
gilt
serum
immun
respons
pedv
va
pedv
gilt
postpartum
pedv
va
gilt
iga
asc
iga
vn
ab
increas
higher
level
faster
rate
compar
mock
va
gilt
suggest
anamnest
respons
pedvinfect
gilt
reexposur
pedv
statu
mock
gilt
time
piglet
pedv
challeng
lastli
gilt
mg
spleen
mln
ileum
tissu
analyz
pedv
iga
igg
asc
pcd
due
high
pedv
rna
shed
titer
fece
mock
litter
mock
gilt
greater
exposur
pedv
pedv
va
infect
gilt
primari
prepartum
secondari
exposur
post
piglet
challeng
therefor
number
mean
iga
asc
spleen
mln
ileum
igg
asc
spleen
ileum
higher
pcd
mock
va
compar
pedv
va
gilt
interestingli
howev
va
supplement
gilt
mock
pedv
group
significantli
higher
mean
pedv
iga
asc
ileum
compar
respect
nonsuppl
counterpart
addit
signific
mean
frequenc
b
cell
ileum
higher
pedv
va
compar
pedv
gilt
data
suggest
va
supplement
effect
local
iga
immun
demonstr
previous
regardless
past
pedv
exposur
potenti
level
traffick
iga
asc
serum
mg
consid
traffick
iga
plasmablast
mg
depend
ra
influenc
depend
b
cell
home
intestin
futur
investig
molecul
cognat
receptor
express
function
vad
model
swine
pregnanc
warrant
indic
va
regul
matern
ab
respons
mucos
pathogen
pregnanc
potenti
applic
promot
health
neonat
remain
unexplor
use
pregnant
swine
model
data
demonstr
va
supplement
third
trimest
pedvinfect
gilt
dual
benefit
mother
neonat
va
supplement
result
less
sever
diarrhea
lower
pedv
rna
shed
titer
pregnant
gilt
suggest
va
supplement
promot
homeostasi
immun
regul
gut
post
pedv
infect
addit
va
supplement
gilt
increas
antipedv
iga
immun
blood
milk
ileum
associ
increas
surviv
rate
pedv
va
litter
post
pedv
challeng
base
innov
approach
result
demonstr
va
enhanc
intestin
immun
pregnanc
lactogen
immun
protect
nurs
piglet
futur
studi
warrant
better
understand
mechan
involv
model
applic
endem
emerg
enter
viral
diseas
human
anim
similar
matern
vaccin
va
supplement
strategi
may
need
enhanc
gutmgsiga
axi
neonat
protect
supplementari
inform
accompani
paper
http
doi
